Boney-Vit

Indications

• Skin disinfection
• Preparation of skin before injections
• Cleansing minor wounds

Dosage

Children: Apply to the skin as required; consult product literature for specific guidance.

Adults: Apply to the skin as required for disinfection.

Mechanism of action

Alcohol exerts its antiseptic effect by denaturing proteins, disrupting cell membranes, and dehydrating microbial cells, leading to cell lysis and death.

Pharmacodynamics

Alcohol has broad-spectrum antimicrobial activity, effective against bacteria, fungi, and viruses. Its efficacy is influenced by concentration, with higher concentrations generally being more effective.

Pharmacokinetics

Alcohol is rapidly absorbed through the skin and mucous membranes. It is metabolized primarily in the liver, with a half-life that varies based on the individual's metabolic rate and the amount consumed.

Contra-indications

• Concomitant use with lithium
• Regular use in neonates
• Patients with severe burns when diathermy has been preceded by application of alcoholic skin disinfectants

Adverse effects

• Eye erythema
• Punctate keratitis
• Cytotoxicity
• Eye discolouration

Interactions

• Increases risk of visual disturbances with antiepileptics
• Increases concentration with methylphenidate
• Increases risk of facial flushing and skin irritation with topical pimecrolimus
• Increases concentration with retinoids
• Increases concentration with acitretin
• Increases risk of facial flushing and skin irritation with topical tacrolimus
• Decreases antidiuretic effect with vasopressin

Precautions

• Avoid regular application to inflamed or broken skin or mucosa
• Avoid broken skin
• Flammable

Pregnancy

Sufficient iodine may be absorbed to affect the fetal thyroid in the second and third trimester.

Breast-feeding

Avoid regular or excessive use.

Storage

Store in a cool, dry place away from heat and direct sunlight.

Formulations

• Betadine 2.5% dry powder spray
• Industrial methylated spirit
• Povidone-Iodine 25 mg per 1 gram

Mechanism of action

Acetone acts as a solvent and is utilized in various biochemical pathways. It participates in the biosynthesis of isopropanol and is involved in the degradation pathways where it converts into other metabolites such as methylglyoxal and acetoacetate. It also plays a role in pyruvate fermentation and is integral to the fermentation processes in Clostridium acetobutylicum.

Pharmacodynamics

Acetone has a low molecular weight and is highly volatile, which allows it to penetrate biological membranes easily. Its pharmacological effects are primarily due to its role as a solvent and its ability to influence metabolic processes. Acetone can affect lipid metabolism and may impact energy homeostasis by influencing the balance between fat and carbohydrate utilization.

Pharmacokinetics

Acetone is rapidly absorbed through inhalation and dermal exposure. It is distributed throughout the body and can cross the blood-brain barrier. Metabolism occurs primarily in the liver where acetone is converted into acetoacetate and other metabolites. The elimination of acetone occurs mainly through renal excretion, with a half-life varying based on the route of exposure and individual metabolism.

Pregnancy

Acetone is classified as a pregnancy category C drug. Its effects during pregnancy are not well-studied, and caution should be exercised.

Breast-feeding

There is limited information on the excretion of acetone in breast milk. Caution is advised when using acetone during breastfeeding.

Storage

Store in a cool, dry place, away from heat and direct sunlight. Keep tightly closed in original container.

Indications

• Dyspepsia
• Flatulence
• Cough
• Insomnia
• Loss of appetite

Dosage

Children: As with adults, dosage for children should be determined by a healthcare provider based on age, weight, and clinical condition.

Adults: Dosage varies based on the form of anise used (e.g., whole seeds, powdered, or oil). Consult a qualified healthcare professional for specific dosing recommendations.

Mechanism of action

The active compounds in anise, particularly anethole, are thought to exert their effects through various mechanisms, including modulation of the gastrointestinal tract's motility, enhancement of mucosal secretion, and antimicrobial activity against a range of pathogens. Anethole may also interact with certain receptors, such as estrogen receptors, contributing to its potential hormonal effects.

Pharmacodynamics

Anise demonstrates several pharmacological effects, including carminative properties, which help alleviate gas and bloating, and antimicrobial effects against certain bacteria and fungi. It may also exhibit antioxidant activity, providing protection against oxidative stress. Anise has been used in traditional medicine for its potential to stimulate appetite and digestive functions, and it may have mild sedative properties.

Pharmacokinetics

The pharmacokinetics of anise have not been extensively studied in clinical settings. However, anise is generally considered to be rapidly absorbed when ingested, with its active constituents metabolized primarily in the liver. The elimination half-life of its key components has not been well-established, but its effects are typically experienced shortly after consumption and may last for a few hours. Anise is primarily excreted in urine as metabolites.

Adverse effects

• Allergic reactions
• Nausea
• Vomiting
• Diarrhea
• Skin irritation

Interactions

• May interact with anticoagulants
• May enhance the effects of sedatives
• Potential interaction with other herbal supplements

Precautions

• Use with caution in individuals with allergies to plants in the Apiaceae family
• Consult healthcare provider if pregnant or breastfeeding
• Monitor for allergic reactions in sensitive individuals

Pregnancy

Not enough reliable information is available regarding the safety of anise during pregnancy. It is advisable to consult a healthcare provider before use.

Breast-feeding

Limited data is available on the safety of anise while breastfeeding. Caution is recommended, and consulting a healthcare provider is advisable.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Whole seeds
• Ground powder
• Essential oil
• Tinctures

Indications

• Dyspepsia
• Flatulence
• Bloating
• Cough relief
• Antimicrobial support

Dosage

Children: Consult appropriate pediatric herbal guidelines, as specific dosing is not universally established.

Adults: Refer to herbal supplement guidelines for dosing, as specific doses can vary widely based on preparation and concentration.

Mechanism of action

Aniseed contains several active compounds, including anethole, which is believed to exert its effects primarily through modulation of the gastrointestinal system. Anethole can stimulate the secretion of digestive enzymes and has been shown to possess antispasmodic properties, potentially alleviating symptoms related to gastrointestinal discomfort. Additionally, its antimicrobial properties may contribute to inhibiting the growth of certain pathogens.

Pharmacodynamics

The pharmacodynamic profile of aniseed is characterized by its ability to enhance digestive function and alleviate symptoms of dyspepsia. Its antispasmodic effects are mediated through inhibition of smooth muscle contractions in the gut. Aniseed may also exhibit mild sedative properties, contributing to its use as a calming herbal remedy. The overall effect is a combination of digestive support and potential relief from gastrointestinal discomfort.

Pharmacokinetics

The pharmacokinetics of aniseed components, particularly anethole, involve oral absorption followed by distribution throughout the body. Anethole is metabolized in the liver and excreted primarily in the urine. The onset of action can vary based on the form of administration, with herbal teas generally producing effects within a few hours, while concentrated extracts may have a more rapid onset. The duration of action is also influenced by the dose and form used.

Adverse effects

• Allergic reactions
• Dermatitis
• Gastrointestinal upset

Interactions

• May interact with anticoagulants, increasing the risk of bleeding
• Can enhance the effects of sedative medications

Precautions

• Use with caution in individuals with a history of allergies, particularly to plants in the Apiaceae family
• May cause skin irritation in sensitive individuals

Pregnancy

Generally considered safe when used in culinary amounts, but high doses should be avoided due to potential hormonal effects.

Breast-feeding

Considered safe when used in culinary amounts, but high doses should be avoided.

Storage

Store in a cool, dry place away from direct sunlight and moisture.

Formulations

• Whole seeds
• Essential oil
• Ground powder

Indications

• Allergic reactions to bee stings
• Arthritis and rheumatism
• Chronic pain management
• Wound healing
• Antimicrobial and anti-inflammatory applications

Dosage

Children: Dosage for children should be determined by a healthcare professional, considering the specific application and the child's age and health status.

Adults: Dosage varies widely based on the specific use and formulation. For bee venom therapy, dosages should be determined by a healthcare professional experienced in apitherapy.

Mechanism of action

Bee venom acts through multiple mechanisms, primarily by interacting with cell membranes and promoting inflammatory responses. Melittin, the main active component, disrupts phospholipid bilayers, leading to cell lysis and the release of pro-inflammatory mediators. Additionally, bee products like honey have antioxidant properties and may modulate immune responses.

Pharmacodynamics

The pharmacodynamics of bee venom includes its ability to induce pain and inflammation through the release of histamines and other inflammatory mediators. Honey has been shown to have antimicrobial properties, promoting wound healing and reducing inflammation. The effects of bee products can vary widely based on the type and concentration of active components present.

Pharmacokinetics

The pharmacokinetics of bee venom are not extensively studied, but components like melittin can enter systemic circulation rapidly following administration. Honey, when ingested, undergoes digestion and absorption in the gastrointestinal tract, with its components being distributed throughout the body. The elimination half-life of bee venom components varies, with some being metabolized by the liver.

Adverse effects

• Allergic reactions
• Anaphylaxis
• Local swelling or pain at the sting site
• Infection at the sting site

Precautions

• Use caution in individuals with known allergies to bee venom or bee products
• Consider the risk of anaphylactic reactions in sensitive individuals
• Monitor for signs of infection at the sting site

Pregnancy

Bees and bee products are generally considered safe during pregnancy, but allergic individuals should avoid exposure.

Breast-feeding

Bee products, such as honey, are typically safe during breastfeeding, but caution is advised for allergic mothers.

Storage

Store bee products in a cool, dry place away from direct sunlight. Bee venom should be handled and stored according to safety guidelines.

Formulations

• Honey
• Bee pollen
• Royal jelly
• Bee venom

Indications

• Food preservative
• Treatment of urea cycle disorders
• Metabolic disorders involving benzoyl-CoA

Dosage

Children: Refer to the BNF for Children for specific dosing guidelines based on condition.

Adults: Refer to the BNF for specific dosing guidelines based on condition.

Mechanism of action

Benzoate acts mainly by inhibiting the growth of bacteria and fungi through its ability to lower the pH, creating an environment that is less favorable for microbial growth. It is also involved in metabolic pathways where it helps in the conjugation of toxic substances, facilitating their excretion from the body.

Pharmacodynamics

Benzoate is known for its antimicrobial properties, which are particularly effective against a wide range of fungi and bacteria. Its efficacy as a preservative is due to its ability to penetrate microbial cell membranes and disrupt their metabolic processes. Additionally, it has been observed to modulate various metabolic pathways, particularly those associated with aromatic compound degradation.

Pharmacokinetics

After ingestion, benzoate is rapidly absorbed in the gastrointestinal tract. It is metabolized primarily in the liver, where it undergoes conjugation with glycine to form hippurate, which is then excreted in the urine. The half-life of benzoate varies depending on individual metabolic rates but is generally short due to its efficient conversion and excretion.

Pregnancy

There is limited data on the use of benzoate in pregnancy. Consultation with healthcare professionals is advised before use.

Breast-feeding

Limited data is available on the excretion of benzoate in breast milk. Caution is recommended when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Acute poisoning
• Drug overdose
• Gastrointestinal decontamination

Dosage

Children: Refer to the BNF for Children for specific dosing guidelines.

Adults: Refer to the BNF for specific dosing guidelines.

Mechanism of action

Carbon does not have a specific mechanism of action as it is a basic element. However, in the context of pharmaceutical applications, activated carbon is used to adsorb toxins and chemicals in the gastrointestinal tract, preventing their absorption into the bloodstream.

Pharmacodynamics

The pharmacodynamic properties of carbon, particularly in the form of activated carbon, relate to its adsorptive capacity. It binds to various substances, including drugs and toxins, thereby reducing their availability and efficacy in the body. This property is utilized in cases of poisoning or overdose.

Pharmacokinetics

Carbon, particularly in its activated form, is not absorbed systemically when administered. Instead, it acts locally within the gastrointestinal tract, adsorbing substances as they pass through. The unabsorbed carbon is excreted in the feces, and its half-life is not applicable since it does not enter systemic circulation.

Pregnancy

Carbon is a fundamental element and is generally regarded as safe during pregnancy as it is a natural component of all living organisms.

Breast-feeding

Carbon is a natural element present in breast milk and is considered safe during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight.

Mechanism of action

Carbonate ions participate in buffering reactions that help maintain pH homeostasis in biological systems. They can react with acids to form bicarbonate and carbon dioxide, thus neutralizing excess acidity in the body. This mechanism is crucial in processes such as respiration and metabolism.

Pharmacodynamics

As a buffer, carbonate helps to stabilize pH levels in different biological environments, preventing excessive acidity or alkalinity that could impair cellular functions. It is involved in the transport of carbon dioxide in the blood and plays a role in maintaining the acid-base equilibrium necessary for physiological processes.

Pharmacokinetics

Carbonate ions are readily absorbed in the gastrointestinal tract when ingested and can be found in various body fluids. They are involved in the bicarbonate buffering system, where they are converted to bicarbonate (HCO3-) and carbon dioxide (CO2) through reactions with acids. The kidneys regulate the levels of bicarbonate and carbonate in the body, excreting or reabsorbing them as needed to maintain homeostasis.

Pregnancy

There is no specific information available regarding the use of carbonate compounds during pregnancy. Consult a healthcare provider for advice.

Breast-feeding

There is no specific information available regarding the use of carbonate compounds while breastfeeding. Consult a healthcare provider for advice.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Emollient in topical preparations
• Thickening agent in creams and ointments
• Coating agent for tablets and capsules
• Food additive for gloss and texture

Dosage

Children: Refer to specific product guidelines for appropriate dosing, as carnauba wax is typically used in formulations rather than prescribed in standalone doses.

Adults: Refer to specific product guidelines for appropriate dosing, as carnauba wax is typically used in formulations rather than prescribed in standalone doses.

Mechanism of action

Carnauba wax acts as a protective layer, providing moisture retention and stability to formulations. Its hydrophobic properties help to reduce moisture loss and improve the overall texture of products.

Pharmacodynamics

Carnauba wax has emollient and film-forming properties, which enhance the stability and consistency of topical and oral formulations. It is non-toxic and generally regarded as safe for use in food and pharmaceuticals, contributing to product palatability and aesthetic appeal.

Pharmacokinetics

Carnauba wax is not significantly absorbed systemically due to its high molecular weight and hydrophobic nature. It is primarily used in topical applications where it forms a barrier on the skin or mucous membranes. Its metabolism is limited, and it is typically excreted unchanged.

Pregnancy

Carnauba wax is generally considered safe during pregnancy as it is a natural product. However, as with any substance, it is advisable to consult a healthcare provider.

Breast-feeding

Carnauba wax is unlikely to cause harm when used in small amounts. Nonetheless, it is best to consult a healthcare provider before use while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Ensure the container is tightly sealed to prevent moisture absorption.

Formulations

• Waxes
• Food additives
• Cosmetic products
• Pharmaceutical coatings

Indications

• Vitamin D deficiency
• Rickets
• Osteomalacia
• Osteoporosis
• Hypoparathyroidism

Dosage

Adults: The usual adult dose for vitamin D deficiency is 800 to 2000 IU daily, depending on the severity of deficiency and clinical condition. Higher doses may be used under medical supervision.

Mechanism of action

Cholecalciferol is converted to its active forms, 25-hydroxyvitamin D in the liver and 1,25-dihydroxyvitamin D in the kidneys. These metabolites enhance the intestinal absorption of calcium and phosphorus, increase serum calcium levels, and mobilize these minerals from bone. This process is regulated by parathyroid hormone, which influences calcium and phosphate metabolism, particularly in the kidneys.

Pharmacodynamics

The pharmacodynamics of cholecalciferol involve its conversion to active metabolites that play a significant role in calcium and phosphorus homeostasis. The metabolites facilitate intestinal absorption of these minerals, promote bone mineralization, and influence renal reabsorption. The onset of action occurs within 10 to 24 hours following administration, as metabolic activation is required for its biological effects.

Pharmacokinetics

Cholecalciferol is absorbed in the gastrointestinal tract, and its absorption is enhanced by the presence of dietary fats. It is transported in the bloodstream bound to vitamin D-binding protein. Once in the liver, it undergoes hydroxylation to form 25-hydroxyvitamin D, which is further converted in the kidneys to the active form, 1,25-dihydroxyvitamin D. The elimination half-life of cholecalciferol varies, typically spanning several days, and it is primarily excreted in bile and urine.

Adverse effects

• Hypercalcemia
• Hypercalciuria
• Nausea
• Vomiting
• Constipation
• Weakness
• Fatigue

Interactions

• May enhance the effects of thiazide diuretics, leading to increased risk of hypercalcemia
• Anticonvulsants may increase metabolism of vitamin D, leading to reduced effectiveness
• Cholestyramine may reduce absorption of vitamin D

Precautions

• Monitor serum calcium levels in patients with renal impairment
• Caution in patients with a history of hypercalcemia or hyperparathyroidism
• Use with caution in patients taking other medications that affect calcium metabolism

Pregnancy

Cholecalciferol can be used during pregnancy if indicated, as vitamin D is essential for fetal bone development.

Breast-feeding

Cholecalciferol is excreted in breast milk, but is generally considered safe during breastfeeding.

Storage

Store in a cool, dry place, away from light. Keep out of reach of children.

Formulations

• Capsules
• Tablets
• Liquid formulations

Mechanism of action

The precise mechanism of action is not well-documented in the provided resources. However, compounds with similar molecular structures often interact with biological pathways through modulation of neurotransmitter systems or receptor activity.

Pharmacodynamics

Pharmacodynamics for compounds like Colour typically involve interactions at the cellular level, influencing physiological responses through receptor binding and modulation of signaling pathways. The specific effects and potency would depend on the context of use and formulation.

Pharmacokinetics

Information on the pharmacokinetics of Colour, including absorption, distribution, metabolism, and excretion, is not provided in the available resources. Generally, pharmacokinetic properties will vary significantly based on formulation and route of administration.

Pregnancy

Safety in pregnancy has not been established. Use only if the benefits outweigh the risks.

Breast-feeding

Caution is advised. There are no adequate studies in breastfeeding women.

Storage

Store in a cool, dry place, away from light. Keep out of reach of children.

Indications

• Aromatherapy
• Anxiety relief
• Mood enhancement
• Antimicrobial applications
• Pain management
• Anti-inflammatory treatments

Dosage

Children: Dosage for paediatric use of essences should be approached with caution and tailored to the child's age, weight, and condition. Refer to specific pediatric guidelines or consult a healthcare provider for appropriate dosing information.

Adults: Dosage for essences varies widely based on the specific type of essence and the intended use. It is essential to refer to specific guidelines or consult a healthcare provider for appropriate dosing information.

Mechanism of action

The mechanism of action of essences can vary depending on the specific substance in question. Generally, essential oils and herbal extracts act through a combination of phytochemical interactions, influencing neurotransmitter systems, modulating inflammation, and exhibiting antimicrobial properties. These compounds may interact with various receptors in the body, including G-protein coupled receptors and ion channels, leading to physiological responses.

Pharmacodynamics

Pharmacodynamics of essences is largely dependent on their chemical composition. Many essential oils contain terpenes, phenols, and other bioactive compounds that exhibit a range of effects such as antibacterial, antifungal, anti-inflammatory, and analgesic properties. The effects can vary based on concentration, route of administration, and individual patient factors, influencing their efficacy and safety.

Pharmacokinetics

The pharmacokinetics of essences involves absorption, distribution, metabolism, and excretion. Essential oils are typically absorbed through the skin or via inhalation and can be distributed throughout the body via the bloodstream. They are often metabolized by the liver, with various pathways leading to the formation of active or inactive metabolites. Excretion mostly occurs through urine, but some components may also be eliminated through bile or exhalation.

Pregnancy

The safety of essence during pregnancy has not been established. Consultation with a healthcare provider is recommended before use.

Breast-feeding

It is unclear whether essence is excreted in breast milk. Caution is advised, and it is best to consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Enhancement of taste in food and beverages
• Improvement of palatability in nutritional products
• Masking undesirable flavors in medications

Dosage

Children: There is no specific pediatric dosage for flavor agents as they are used as needed to improve the taste of food and beverages.

Adults: There is no specific dosage for flavor agents as they are used as needed to achieve the desired taste and aroma in food and beverages.

Mechanism of action

Flavor compounds interact with taste receptors on the tongue, stimulating the sensory neurons responsible for taste perception. This interaction influences the overall flavor profile of food and beverages, enhancing the eating experience. Some flavors may also have a psychological effect, stimulating appetite or evoking pleasant memories associated with certain tastes.

Pharmacodynamics

While flavor agents are primarily used for sensory enhancement in food, their pharmacodynamic effects are minimal as they are not designed to elicit a pharmacological response. However, certain flavors may influence digestion and metabolism indirectly by enhancing saliva production or affecting gut motility. The enjoyment of flavored products can also lead to increased food intake and satisfaction.

Pharmacokinetics

Flavour compounds are typically ingested and metabolized by the body. Their absorption rates can vary depending on their chemical structure and formulation. Once ingested, they may be rapidly metabolized in the liver and other tissues, with excretion primarily via urine. The specific pharmacokinetic profiles of flavor agents can vary significantly based on their source and chemical properties.

Pregnancy

Flavours are generally considered safe for use during pregnancy, but specific assessments should be made based on the type of flavouring agent.

Breast-feeding

Most flavouring agents are deemed safe during breastfeeding, although it's advisable to consult healthcare professionals regarding specific ingredients.

Storage

Store in a cool, dry place away from direct sunlight and heat sources. Ensure that the container is tightly sealed to prevent contamination.

Dosage

Children: Specific dosing information is not applicable without a defined drug.

Adults: Specific dosing information is not applicable without a defined drug.

Dosage

Children: Refer to specific guidelines for pediatric dosing; consult the BNF for Children for accurate dosage information.

Adults: Refer to specific guidelines for use; dosage may vary based on the context of use.

Mechanism of action

Hydroxide ions act primarily as bases, neutralizing acids to form water and salts. They participate in various biochemical pathways, including selenium metabolism and the degradation of reactive oxygen species. Hydroxide can influence enzyme activity and stability by altering the pH of the environment, thereby affecting metabolic reactions.

Pharmacodynamics

Hydroxide ions can impact biological processes by changing the local pH, which influences enzyme activity, ion transport, and the solubility of other compounds. Their ability to neutralize acids can help regulate physiological pH, contributing to homeostasis in living organisms.

Pharmacokinetics

As an inorganic ion, hydroxide does not undergo traditional pharmacokinetic processes like absorption, distribution, metabolism, or excretion. Instead, it is rapidly equilibrated in biological fluids and participates in acid-base reactions, having immediate effects on the local environment.

Pregnancy

There is limited information regarding the use of hydroxide during pregnancy. Consult a healthcare professional for advice.

Breast-feeding

Limited data is available on the excretion of hydroxide in breast milk. Consult a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Topical analgesic for muscle and joint pain
• Cough suppressant in cough drops and lozenges
• Relief of minor throat irritation
• Cooling agent in various cosmetic and personal care products

Dosage

Children: Refer to BNF for Children for specific dosing guidelines, as doses may vary based on age and formulation.

Adults: For topical use, apply a thin layer to the affected area not more than 3 to 4 times daily. For cough drops, follow the product-specific instructions as per the formulation.

Mechanism of action

Menthol acts as an agonist for the transient receptor potential subtype M8 (TRPM8), a non-selective cation channel that is activated by cold temperatures. This activation leads to calcium influx in mast cells, inducing the release of histamine, which can trigger allergic responses such as urticaria, asthma, and rhinitis. Menthol's ability to induce histamine release via TRPM8 suggests potential therapeutic applications for TRPM8 antagonists in managing cold- and menthol-induced allergies.

Pharmacodynamics

Menthol produces a cooling effect by stimulating sensory neurons that convey cold sensations. It interacts with TRPM8 channels, leading to the activation of intracellular signaling pathways that can result in vasodilation and increased blood flow to the area of application. This cooling sensation can provide symptomatic relief in conditions characterized by pain or irritation.

Pharmacokinetics

Menthol is absorbed through the skin and mucous membranes, with systemic effects depending on the route of administration. Its bioavailability can vary, and it is metabolized primarily in the liver. The elimination half-life and excretion pathways have not been extensively characterized, but menthol is generally considered to have a rapid onset of action with effects lasting for a few hours.

Adverse effects

• Allergic reactions
• Urticaria
• Asthma
• Rhinitis
• Skin irritation

Precautions

• Use with caution in patients with known allergies to menthol or related compounds
• May exacerbate asthma in sensitive individuals

Pregnancy

There are no well-controlled studies of menthol in pregnant women. Menthol should be used during pregnancy only if clearly needed.

Breast-feeding

Menthol is excreted in breast milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Topical ointment
• Cream
• Liquid

Dosage

Adults: Refer to specific guidelines for management of methyl mercaptan exposure, as there are no established therapeutic doses due to its toxicity.

Mechanism of action

Methyl mercaptan exerts its toxic effects primarily through the reversible inhibition of cytochrome c oxidase, similar to mechanisms observed in cyanide and hydrogen sulfide poisoning. It also inhibits brain sodium and potassium ATPase activity. These mechanisms contribute to its potential to induce coma and other neurological disturbances. Additionally, methyl mercaptan has been implicated in the pathogenesis of hepatic coma, indicating its impact on liver function and metabolism. The compound stabilizes erythrocyte membranes against hypotonic hemolysis at low concentrations, which may be linked to its anesthetic properties.

Pharmacodynamics

The pharmacodynamics of methyl mercaptan involve its ability to disrupt normal cellular respiratory processes and membrane stability. The inhibition of cytochrome c oxidase leads to impaired oxidative phosphorylation, causing cellular hypoxia. Furthermore, its effect on sodium and potassium ATPase can disrupt ionic balance within cells, potentially leading to cellular dysfunction and death. The compound's anesthetic-like effects differentiate it from common anesthetics, particularly in its toxicity profile, as it can elicit significant adverse reactions even at lower concentrations.

Pharmacokinetics

The pharmacokinetics of methyl mercaptan are not extensively characterized in clinical literature, but it is known to be rapidly absorbed through inhalation. Once in the body, it is likely metabolized by the liver, consistent with its involvement in hepatic coma. The gas is highly soluble in water and biological fluids, which may facilitate its distribution throughout tissues. Elimination pathways are not well defined, but it is presumed to be excreted through respiration and potentially other metabolic routes.

Pregnancy

There is limited information on the safety of methyl mercaptan in pregnancy. It is advisable to avoid exposure whenever possible due to potential risks.

Breast-feeding

The effects of methyl mercaptan during breastfeeding are not well studied. Caution is recommended due to the potential for unknown risks.

Storage

Store in a cool, dry place away from light and heat. Ensure containers are tightly sealed to prevent exposure and contamination.

Indications

• Allergic conditions
• Autoimmune diseases
• Asthma and chronic obstructive pulmonary disease (COPD)
• Certain cancers (e.g., leukemia, lymphoma)
• Skin conditions (e.g., dermatitis)
• Inflammatory bowel disease
• Multiple sclerosis exacerbations
• Severe infections requiring immunosuppression

Dosage

Children: Refer to BNF for Children for specific dosing; doses vary significantly based on the child's age, weight, and condition being treated.

Adults: Refer to BNF for specific dosing; typically, initial doses range from 4 to 48 mg depending on the severity of the condition.

Mechanism of action

Methylprednisolone exerts its effects by binding to glucocorticoid receptors, leading to the modulation of gene expression. This interaction influences the transcription of anti-inflammatory proteins while suppressing the expression of pro-inflammatory genes, ultimately resulting in reduced inflammation and immune response.

Pharmacodynamics

The pharmacodynamic effects of methylprednisolone are characterized by its ability to decrease inflammation, suppress the immune response, and affect carbohydrate metabolism. Therapeutic doses lead to various systemic effects, including modification of leukocyte distribution and inhibition of cytokine production.

Pharmacokinetics

Methylprednisolone is well absorbed after oral administration, with a bioavailability of approximately 50%. It has a volume of distribution that reflects extensive tissue binding. The drug is metabolized primarily in the liver through conjugation and reduction, and its metabolites are excreted in urine. The half-life varies based on the route of administration but is generally around 18 to 36 hours.

Adverse effects

• Increased blood pressure
• Hyperglycemia
• Weight gain
• Mood changes
• Insomnia
• Gastrointestinal disturbances
• Increased susceptibility to infections

Interactions

• methylphenidate+apraclonidine: Severe (decreases effects)
• methylthioninium chloride+bupropion: Severe (increases risk of severe hypertension)
• methylphenidate+linezolid: Severe (increases risk of elevated blood pressure)
• rasagiline+methylphenidate: Severe (increases risk of a hypertensive crisis)
• mao-inhibitors+methylphenidate: Severe (increases risk of a hypertensive crisis)
• dronedarone+methylprednisolone: Moderate (increases exposure)
• miconazole+methylprednisolone: Moderate (increases concentration)
• antifungals, azoles+methylprednisolone: Moderate (increases exposure)
• crizotinib+methylprednisolone: Moderate (increases exposure)

Precautions

• Use with caution in patients with hypertension
• Monitor blood glucose levels in diabetic patients
• Consider potential for infection risk due to immunosuppression
• Evaluate for psychiatric effects in susceptible individuals

Pregnancy

Corticosteroids may be used during pregnancy if the potential benefit justifies the risk to the fetus. Careful monitoring is advised.

Breast-feeding

Corticosteroids are excreted in breast milk; caution is advised. Monitor the infant for potential effects.

Storage

Store in a cool, dry place, away from light. Keep out of reach of children.

Formulations

• Tablets
• Injectable solutions
• Topical preparations

Mechanism of action

Methylsulphate functions as a methylating agent, transferring a methyl group to nucleophiles. This process involves the formation of a sulfonium ion, which is highly reactive and can readily react with nucleophilic sites on various substrates, leading to methylation reactions.

Pharmacodynamics

The pharmacodynamics of methylsulphate is primarily related to its role as a methylating agent in biochemical reactions. It can alter the structure and function of biological molecules, potentially affecting cellular processes and signaling pathways. However, detailed pharmacodynamic studies specific to therapeutic use are limited.

Pharmacokinetics

There is limited information on the pharmacokinetics of methylsulphate, given its typical use as a reagent in laboratory settings rather than a clinical drug. When used in chemical reactions, its reactivity and transformation into other compounds would dictate its pharmacokinetic profile, which could vary significantly based on the specific context of use.

Pregnancy

There is limited data on the use of methylsulphate in pregnancy. Consult relevant guidelines.

Breast-feeding

Data on the excretion of methylsulphate in human milk is not available. Caution is advised.

Storage

Store in a cool, dry place, away from direct sunlight.

Indications

• Preservative in cosmetics
• Preservative in pharmaceuticals
• Preservative in food products

Dosage

Children: Refer to specific product guidelines as dosing varies based on formulation and concentration used.

Adults: Refer to specific product guidelines as dosing varies based on formulation and concentration used.

Mechanism of action

Parabens work by inhibiting the growth of microorganisms through their ability to disrupt the cellular processes of bacteria and fungi. They penetrate the microbial cell membrane and disrupt enzyme and protein functions, leading to cell death. Parabens are known to have low toxicity and are metabolized by the body, subsequently being excreted in urine.

Pharmacodynamics

Parabens demonstrate broad-spectrum antimicrobial activity, making them effective preservatives in various formulations. Their efficacy is influenced by factors such as concentration, pH, and the presence of other ingredients in the formulation. Due to their structural similarity to estrogen, there has been concern regarding their potential endocrine-disrupting effects, although the clinical significance of this is still debated.

Pharmacokinetics

Parabens are readily absorbed through the skin and gastrointestinal tract. Once absorbed, they are rapidly metabolized primarily in the liver. They undergo hydrolysis to form para-hydroxybenzoic acid, which is then conjugated with glucuronic acid and excreted in urine. The half-life of parabens in the human body is relatively short, and they are eliminated rapidly.

Adverse effects

• Allergic reactions, such as skin rashes
• Irritation at the site of application
• Endocrine disruption (in high concentrations)

Precautions

• Use with caution in individuals with known sensitivities or allergies to parabens
• Consider potential endocrine effects with prolonged exposure

Pregnancy

Parabens are generally considered safe in cosmetics and personal care products during pregnancy, although caution is advised due to potential endocrine disruption.

Breast-feeding

Parabens are considered safe in breastfeeding, but it is recommended to use products with minimal or no parabens when possible.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Topical creams
• Lotions
• Shampoos
• Conditioners
• Makeup products
• Pharmaceutical preparations

Indications

• Atrial fibrillation
• Atrial flutter
• Ventricular tachycardia
• Ventricular fibrillation
• Supraventricular tachycardia

Dosage

Children: Refer to the BNF for Children for specific dosing guidelines tailored to the paediatric population.

Adults: Refer to the BNF for specific dosing guidelines based on the condition being treated and the patient's individual characteristics.

Mechanism of action

Amiodarone acts by inhibiting adrenergic stimulation, blocking the sodium channels, and prolonging the myocardial cell action potential and refractory period. It also has calcium channel blocking properties and can inhibit the effects of catecholamines on the heart. The complex mechanism results in decreased heart rate, increased atrial and ventricular refractory periods, and overall stabilization of the cardiac rhythm.

Pharmacodynamics

The drug exhibits a dose-dependent effect on cardiac conduction and can alter the electrophysiological properties of the heart. Its antiarrhythmic effects are primarily due to the blockade of sodium and potassium channels, leading to a prolongation of the action potential duration and refractory period. It also affects the autonomic nervous system's control over the heart, contributing to its efficacy in arrhythmias.

Pharmacokinetics

Amiodarone is well absorbed from the gastrointestinal tract, with a long half-life that can vary from several days to weeks. It is highly lipophilic, leading to extensive tissue distribution, particularly in the lungs, liver, and heart. It is metabolized primarily in the liver by cytochrome P450 enzymes, and its elimination is predominantly through biliary excretion. Due to its long half-life, it may take several weeks to reach steady-state conditions.

Pregnancy

No data available, consult specific guidelines.

Breast-feeding

No data available, consult specific guidelines.

Storage

Store in a cool, dry place away from light.

Indications

• Irritable bowel syndrome
• Dyspepsia
• Nausea
• Headaches
• Respiratory congestion

Dosage

Children: Refer to the BNF for Children for appropriate dosing guidelines.

Adults: Refer to the relevant product-specific information for dosing recommendations, as peppermint formulations can vary widely.

Mechanism of action

The primary active component, menthol, works by activating the TRPM8 (transient receptor potential cation channel subfamily M member 8) ion channel, which is involved in the sensation of cold and cooling. This action can lead to a localized anesthetic effect, reducing pain and discomfort. Additionally, menthol can cause relaxation of smooth muscle in the gastrointestinal tract, aiding in the relief of digestive symptoms.

Pharmacodynamics

Peppermint exhibits antispasmodic effects, particularly in the gastrointestinal tract, by relaxing the smooth muscles. It also has a mild analgesic effect due to its cooling sensation, which can provide symptomatic relief in various conditions. Furthermore, peppermint oil may have antimicrobial properties, contributing to its use in treating certain infections.

Pharmacokinetics

Menthol is rapidly absorbed after oral administration and is metabolized in the liver. The peak plasma concentration typically occurs within a few hours. The elimination half-life of menthol is approximately 1.5 to 2 hours, and it is primarily excreted in the urine as metabolites. The pharmacokinetics of peppermint oil can vary based on the formulation and route of administration.

Interactions

• peppermint oil + lomitapide: Unknown (increases exposure)

Pregnancy

Peppermint is generally considered safe for use in pregnancy when used in culinary amounts. However, high doses should be avoided due to potential uterine stimulation.

Breast-feeding

Peppermint is considered safe during breastfeeding when used in culinary amounts. Caution is advised with high doses as effects on the infant are not well studied.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Peppermint oil
• Peppermint extract
• Peppermint tea

Dosage

Children: For specific paediatric dosing, refer to the BNF for Children.

Adults: For specific dosing, refer to the BNF or relevant drug-specific guidelines.

Mechanism of action

Pharmaceuticals work through a variety of mechanisms depending on the specific drug. Common mechanisms include receptor modulation, enzyme inhibition, ion channel blockade, and alteration of neurotransmitter levels. For example, many analgesics act by inhibiting cyclooxygenase enzymes, leading to decreased production of pro-inflammatory compounds.

Pharmacodynamics

Pharmacodynamics involves how drugs exert their effects on the body. This includes the relationship between drug concentration and effect, the duration of action, and the therapeutic window. The efficacy and safety of a drug are determined by its pharmacodynamic properties, including its potency, selectivity for its target, and the biochemical pathways it influences.

Pharmacokinetics

Pharmacokinetics refers to the absorption, distribution, metabolism, and excretion (ADME) of drugs. This includes how a drug is absorbed into the bloodstream, its distribution throughout the body, how it is metabolized by enzymes (often in the liver), and its route of excretion (usually via urine or feces). These processes determine the onset, intensity, and duration of a drug's action.

Pregnancy

Consult a healthcare professional before use. Safety during pregnancy has not been established.

Breast-feeding

Consult a healthcare professional before use. Safety during breastfeeding has not been established.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Hyperthyroidism
• Graves' disease
• Thyroid storm

Dosage

Children: Refer to the BNF

Adults: The usual initial dose of propylthiouracil in adults is 300 mg per day, divided into 3 doses. The maintenance dose is typically 100-150 mg per day, adjusted based on thyroid function tests.

Mechanism of action

Propylthiouracil acts by inhibiting the enzyme thyroid peroxidase, which is involved in the iodination of tyrosine residues in thyroglobulin, a precursor of thyroid hormones. By blocking this enzyme, PTU reduces the production of thyroxine (T4) and triiodothyronine (T3), leading to decreased thyroid hormone levels in circulation. Additionally, PTU inhibits the conversion of T4 to T3 in peripheral tissues, further contributing to its antithyroid effects.

Pharmacodynamics

The pharmacodynamic effects of propylthiouracil are primarily centered around its ability to lower thyroid hormone levels, which helps alleviate symptoms of hyperthyroidism such as increased heart rate, weight loss, and anxiety. The onset of action can vary, but therapeutic effects may be observed within several weeks of initiation. Monitoring thyroid function tests is essential to assess the efficacy and adjust dosing as needed.

Pharmacokinetics

Propylthiouracil is well absorbed from the gastrointestinal tract, though its bioavailability can be affected by factors such as food intake. The drug is extensively metabolized in the liver, and its elimination half-life averages around 1-2 hours. Most of the drug is excreted in urine as metabolites. It is important to note that due to its rapid metabolism, multiple daily doses may be required to maintain therapeutic levels.

Interactions

• propylthiouracil+metyrapone: Severe (decreases effects)

Dosage

Children: Refer to specific drug guidelines as pulverised medication doses vary widely based on the active ingredient.

Adults: Refer to specific drug guidelines as pulverised medication doses vary widely based on the active ingredient.

Mechanism of action

The mechanism of action of pulverised drugs depends on the specific active pharmaceutical ingredient (API) present. Generally, pulverisation improves the dissolution rate of drugs, which can enhance their absorption in the gastrointestinal tract or other delivery systems. Increased surface area allows for faster interaction with solvents, facilitating the release of the active compound into systemic circulation.

Pharmacodynamics

Pharmacodynamics varies widely based on the specific drug being pulverised. However, pulverisation often leads to enhanced therapeutic effects due to improved solubility and absorption. The fine particles can lead to faster onset of action and potentially higher peak plasma concentrations, depending on the drug's properties.

Pharmacokinetics

Pharmacokinetics is specific to the active ingredient. Generally, pulverised formulations may exhibit altered absorption profiles, leading to changes in peak plasma levels, time to peak concentration, and overall bioavailability. The distribution, metabolism, and excretion of the drug will also depend on its chemical properties and the route of administration, but pulverisation typically aims to optimize these processes.

Pregnancy

Safety during pregnancy has not been established; use only if clearly needed.

Breast-feeding

Caution is advised; consult a healthcare provider before use.

Storage

Store in a cool, dry place, away from direct sunlight and moisture.

Indications

• Nutritional supplement
• Support for cardiovascular health
• Anti-inflammatory effects
• Digestive health
• Weight management

Dosage

Children: Refer to specific seed type guidelines; general recommendations vary widely based on the preparation and intended use.

Adults: Refer to specific seed type guidelines; general recommendations vary widely based on the preparation and intended use.

Mechanism of action

The mechanism of action of seeds varies widely based on the type of seed. Generally, seeds contain bioactive compounds such as flavonoids, alkaloids, and essential fatty acids that may exert antioxidant, anti-inflammatory, and immunomodulatory effects. For example, flaxseeds are rich in omega-3 fatty acids, which can modulate inflammatory pathways and promote cardiovascular health.

Pharmacodynamics

Seeds exhibit a range of pharmacodynamic effects, including antioxidant activity, lipid-lowering effects, and potential anti-cancer properties. The specific effects depend on the type of seed and its constituents. For instance, chia seeds are known for their high fiber content, which can aid in digestion and glycemic control. Additionally, some seeds may influence hormone levels or metabolic pathways, contributing to various health benefits.

Pharmacokinetics

The pharmacokinetics of seeds is highly variable and depends on the type of seed and its chemical composition. Generally, the bioavailability of nutrients from seeds can be influenced by factors such as preparation and processing methods. For example, the oil extracted from seeds can be absorbed more readily than whole seeds. The metabolism of specific active compounds may occur in the liver, and excretion is typically via urine or feces, depending on their solubility.

Pregnancy

The use of seeds in pregnancy should be approached with caution, and it is advisable to consult a healthcare professional before consumption.

Breast-feeding

Consultation with a healthcare provider is recommended before using seeds while breastfeeding, as some seeds may affect milk production or composition.

Storage

Seeds should be stored in a cool, dry place away from direct sunlight to maintain freshness and prevent spoilage.

Dosage

Children: Refer to the specific drug's prescribing information for paediatric dosing guidelines.

Adults: Refer to the specific drug's prescribing information for adult dosing guidelines.

Mechanism of action

The mechanism of action would depend on the specific drug referred to by 'size'. Generally, drugs exert their effects through interaction with biological targets such as receptors, enzymes, or ion channels, leading to a physiological response.

Pharmacodynamics

Pharmacodynamics refers to the effects of the drug on the body, including the relationship between drug concentration and effect. This can involve receptor binding, signal transduction, and the resulting biological effects. Specific dynamics would vary based on the drug in question.

Pharmacokinetics

Pharmacokinetics describes the absorption, distribution, metabolism, and excretion (ADME) of a drug. Factors such as bioavailability, volume of distribution, half-life, and clearance would vary significantly based on the specific drug being considered.

Pregnancy

Safety in pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Use with caution, as it is not known whether it is excreted in human milk.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Sweetening agent in food and beverages
• Ingredient in pharmaceutical formulations
• Source of quick energy

Dosage

Children: Refer to specific formulations and clinical guidelines for dosing, as sucrose does not have a standardized dosage. Typically used as needed for sweetening.

Adults: Refer to specific formulations and clinical guidelines for dosing, as sucrose does not have a standardized dosage. Typically used as needed for sweetening.

Mechanism of action

Sucrose is metabolized in the body to glucose and fructose, which are then used as energy sources. It does not have a specific pharmacological mechanism of action but contributes to energy metabolism via the glycolytic and citric acid pathways.

Pharmacodynamics

Upon ingestion, sucrose is hydrolyzed by the enzyme sucrase into its constituent monosaccharides, glucose and fructose. These monosaccharides are absorbed in the small intestine and enter the bloodstream, leading to a rise in blood glucose levels. This process provides a quick source of energy for cellular functions.

Pharmacokinetics

Sucrose is rapidly absorbed in the gastrointestinal tract after hydrolysis. Its absorption depends on the presence of sucrase in the intestine. Once in the bloodstream, glucose can be utilized by cells or stored as glycogen in the liver and muscles. The elimination half-life of sucrose itself is not well-defined as it is quickly broken down and utilized.

Pregnancy

Sucrose is generally regarded as safe during pregnancy when consumed in moderation as part of a balanced diet.

Breast-feeding

Sucrose is considered safe during breastfeeding when consumed in normal dietary amounts.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Oral solution
• Granules
• Tablets

Dosage

Children: Refer to product-specific guidelines or consult a healthcare professional.

Adults: Refer to product-specific guidelines or consult a healthcare professional.

Pregnancy

There is limited data on the safety of Sunset during pregnancy, thus it should be used only if clearly needed and prescribed by a healthcare provider.

Breast-feeding

Due to the lack of sufficient studies, it is advised to consult a healthcare professional before using Sunset while breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight and out of reach of children.

Indications

• Magnetic resonance imaging (MRI) contrast enhancement
• Drug delivery systems
• Potential therapeutic applications in oncology

Dosage

Children: Refer to the BNF for Children for appropriate pediatric dosing information.

Adults: Refer to the specific guidelines for dosage as per BNF and clinical protocols.

Mechanism of action

The principal uptake mechanism for superparamagnetic iron oxide nanoparticles involves clathrin-mediated endocytosis that is dependent on scavenger receptor A. This process allows phagocytic cells, particularly macrophages, to internalize the nanoparticles effectively. The interaction of these nanoparticles with macrophages is critical for their application in imaging and potential therapeutic interventions.

Pharmacodynamics

Superparamagnetic iron oxide nanoparticles exhibit properties that enhance the visibility of tissues during imaging procedures. Their magnetic properties allow for a significant increase in contrast during MRI scans. Additionally, they may have implications in therapeutic contexts, such as in the targeting of cancer cells, where their uptake by macrophages could facilitate localized drug delivery.

Pharmacokinetics

The pharmacokinetics of superparamagnetic iron oxide nanoparticles are characterized by rapid uptake by phagocytic cells, particularly in the liver and spleen. Following systemic administration, these nanoparticles are primarily cleared by macrophages through endocytosis. The particles tend to accumulate in the reticuloendothelial system, which can influence their distribution and elimination from the body.

Pregnancy

There is limited data on the safety of iron oxide nanoparticles during pregnancy. Caution is advised.

Breast-feeding

Limited data is available regarding the excretion of iron oxide nanoparticles in breast milk. Caution is advised.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Carboxydextran-coated superparamagnetic iron oxide nanoparticles

Dosage

Children: Refer to relevant safety guidelines, as specific dosing information for clinical use is not provided in the BNF.

Adults: Refer to relevant safety guidelines, as specific dosing information for clinical use is not provided in the BNF.

Mechanism of action

Tetrachloride is a non-polar solvent that dissolves a wide range of organic compounds. It disrupts cellular membranes and can interfere with metabolic processes by forming reactive intermediates, leading to cellular damage. The mechanism may also involve the induction of oxidative stress and mitochondrial dysfunction.

Pharmacodynamics

The pharmacodynamic effects of tetrachloride are primarily linked to its role as a solvent and its cytotoxic properties. It can cause cellular damage, particularly in the liver, through lipid peroxidation and disruption of cellular integrity. Its effects may vary based on exposure duration, concentration, and route of administration, leading to acute or chronic toxicity.

Pharmacokinetics

Tetrachloride is absorbed through the respiratory tract, gastrointestinal tract, and skin. Once in the bloodstream, it distributes widely throughout body tissues, particularly in adipose tissue and the liver, where it undergoes biotransformation via cytochrome P450 enzymes. The elimination half-life can vary, but it is primarily excreted through the urine as metabolites. Accumulation may occur with prolonged exposure, leading to increased toxicity.

Pregnancy

There is insufficient data on the safety of tetrachloride in pregnancy. Caution is advised.

Breast-feeding

Caution is advised as the effects on nursing infants are not well-studied.

Storage

Store in a cool, dry place away from direct sunlight and heat sources. Keep in tightly closed containers.

Dosage

Children: Refer to specific drug information for paediatric dosing guidelines, as this will depend on the active compound and its therapeutic use.

Adults: Refer to specific drug information for adult dosing guidelines, as this will depend on the active compound and its therapeutic use.

Mechanism of action

The mechanism of action will depend on the specific active compound that is in the tetrahydrate form. Generally, tetrahydrates can improve the bioavailability of a drug by facilitating its dissolution in bodily fluids, which can enhance absorption in the gastrointestinal tract.

Pharmacodynamics

Pharmacodynamics will vary based on the specific drug in the tetrahydrate form. However, it generally involves the interaction of the drug with specific receptors or enzymes in the body, influencing physiological and biochemical processes. Tetrahydrate forms may affect the pharmacokinetics of the drug, altering its efficacy and safety profile.

Pharmacokinetics

Pharmacokinetics of a tetrahydrate form will depend on the parent compound. Typically, factors such as absorption, distribution, metabolism, and excretion can be influenced by the hydration state of the drug. Hydrates may have different solubility and stability profiles, which can impact the rate and extent of drug absorption.

Dosage

Children: Refer to specific guidelines or clinical recommendations for appropriate dosing.

Adults: Refer to specific guidelines or clinical recommendations for appropriate dosing.

Mechanism of action

Tetraphosphate acts as a phosphate donor in biochemical reactions, participating in the transfer of phosphate groups to other molecules. This mechanism is essential in the regulation of metabolic pathways and energy production within cells.

Pharmacodynamics

As a polyphosphate, tetraphosphate influences cellular processes by modulating the availability of phosphate. The compound is involved in energy metabolism, particularly in the synthesis and hydrolysis of ATP, and may also impact nucleic acid metabolism and signaling pathways that rely on phosphate.

Pharmacokinetics

The pharmacokinetics of tetraphosphate are not well-documented; however, it is generally assumed that, like other phosphate compounds, it may be absorbed and utilized in various tissues, with renal excretion being a likely route for elimination.

Indications

• pH stabilization in pharmaceutical formulations
• solubilization of poorly soluble drugs
• buffering agent in injectable preparations

Dosage

Children: Refer to specific product guidelines for paediatric dosing as it may vary based on formulation.

Adults: Refer to specific product guidelines for adult dosing as it may vary based on formulation.

Mechanism of action

Tetrasodium functions primarily as a buffering agent, helping to maintain the pH of pharmaceutical preparations. This stabilization is crucial in ensuring the solubility and bioavailability of active pharmaceutical ingredients, thereby enhancing their therapeutic effects.

Pharmacodynamics

The pharmacodynamic properties of tetrasodium relate to its ability to modulate pH levels in a solution. By maintaining optimal pH conditions, tetrasodium aids in preserving the stability and efficacy of various drugs, improving their overall therapeutic action.

Pharmacokinetics

Tetrasodium is generally not absorbed systemically when used in pharmaceutical formulations, as its primary role is localized within the preparation. Its pharmacokinetic profile is largely influenced by its solubility and stability in solution, which can affect the release and absorption of the active ingredients it is combined with.

Pregnancy

No specific data available, consult a healthcare professional.

Breast-feeding

No specific data available, consult a healthcare professional.

Storage

Store in a cool, dry place away from light.

Mechanism of action

Ethanol affects the brain’s neurons in several ways. It alters their membranes as well as their ion channels, enzymes, and receptors. Alcohol also binds directly to the receptors for acetylcholine, serotonin, GABA, and the NMDA receptors for glutamate. The sedative effects of ethanol are mediated through binding to GABA receptors and glycine receptors (alpha 1 and alpha 2 subunits). It also inhibits NMDA receptor functioning. In its role as an anti-infective, ethanol acts as an osmolyte or dehydrating agent that disrupts the osmotic balance across cell membranes. ... Ethanol is known to affect a large number of membrane proteins that participate in signaling pathways such as neurotransmitter receptors, enzymes, and ion channels, and there is extensive evidence that ethanol interacts with a variety of neurotransmitters. The major actions of ethanol involve enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) at GABAa receptors and blockade of the N-methyl-D-aspartate (NMDA) subtype of glutamate, an excitatory amine acid (EAA) receptor. Animal studies indicate that the acute effects of ethanol result from competitive inhibition of glycine binding to NMDA receptor and disruption of glutamatergic neurotransmission by inhibiting the response of the NMDA receptor. Persistent glycine antagonism and attenuation of glutamatergic neurotransmission by chronic ethanol exposure results in tolerance to ethanol by enhancing EAA neurotransmission and NMDA receptor upregulation. The latter appears to involve selective increases in NMDA R2B subunit concentrations and other molecular changes in specific brain loci. The abrupt withdrawal of ethanol thus produces a hyperexcitable state that leads to the ethanol withdrawal syndrome and excitotoxic neuronal death. GABA-mediated inhibition, which normally acts to limit excitation, is eliminated during ethanol withdrawal syndrome and further intensifies this excitation. In addition, NMDA receptors function to inhibit the release of dopamine in the nucleus accumbens and mesolimbic structures, which modulate the reinforcing action of addictive xenobiotics such as ethanol. By inhibiting NMDA receptor activity, ethanol could increase dopamine release from the nucleus accumbens and ventral tegmental area and could thus create dependence. Chronic ethanol administration also results in tolerance, dependence, and an ethanol withdrawal syndrome, mediated, in part, by desensitization and or downregulation of GABAa receptors. The development of alcoholic ketoacidosis (AKA) requires that a combination of physical and physiologic events occur. The normal response to starvation and depletion of hepatic glycogen stores is for amino acids to be converted to pyruvate. Pyruvate can serve as a substrate for gluconeogenesis, be converted to acetyl-CoA, which can enter the Krebs cycle or can be utilized in various biosynthetic pathways (eg, fatty acid, ketone bodies, cholesterol, and acetylcholine) ... Ethanol metabolism generates NADH, resulting in an excess of reducing potential. This high redox state favors the conversion of pyruvate to lactate, diverting pyruvate from being a substrate for gluconeogenesis. To compensate for the lack of normal metabolic substrates, the body mobilizes fat from adipose tissue and increased fatty acid metabolism as an alternative source of energy. This response is mediated by a decrease in insulin and an increased secretion of glucagon, catecholamines, growth hormone, and cortisol. Fatty acid metabolism results in the formation of acetyl-CoA and it combines with the excess acetate that is generated from ethanol metabolism to form acetoacetate. Most of the acetoacetate is reduced to beta-hydroxybutyrate due to the excess reducing potential or high redox state of the cell. Volume depletion interferes with the renal elimination of acetoacetate and beta-hydroxybutyrate, and contributes to the acidosis. An elevated lactate concentration may result from shunting from pyruvate or

Pharmacodynamics

Alcohol produces injury to cells by dehydration and precipitation of the cytoplasm or protoplasm. This accounts for its bacteriocidal and antifungal action. When alcohol is injected in close proximity to nerve tissues, it produces neuritis and nerve degeneration (neurolysis). Ninety to 98% of ethanol that enters the body is completely oxidized. Ethanol is also used as a cosolvent to dissolve many insoluble drugs and to serve as a mild sedative in some medicinal formulations. Ethanol also binds to GABA, glycine, NMDA receptors and modulates their effects. Ethanol is also metabolised by the hepatic enzyme alcohol dehydrogenase.

Mechanism of action

Most individuals naturally generate adequate amounts of vitamin D through ordinary dietary intake of vitamin D (in some foods like eggs, fish, and cheese) and natural photochemical conversion of the vitamin D3 precursor 7-dehydrocholesterol in the skin via exposure to sunlight. Conversely, vitamin D deficiency can often occur from a combination of insufficient exposure to sunlight, inadequate dietary intake of vitamin D, genetic defects with endogenous vitamin D receptor, or even severe liver or kidney disease. Such deficiency is known for resulting in conditions like rickets or osteomalacia, all of which reflect inadequate mineralization of bone, enhanced compensatory skeletal demineralization, resultant decreased calcium ion blood concentrations, and increases in the production and secretion of parathyroid hormone. Increases in parathyroid hormone stimulate the mobilization of skeletal calcium and the renal excretion of phosphorus. This enhanced mobilization of skeletal calcium leads towards porotic bone conditions. Ordinarily, while vitamin D3 is made naturally via photochemical processes in the skin, both itself and vitamin D2 can be found in various food and pharmaceutical sources as dietary supplements. The principal biological function of vitamin D is the maintenance of normal levels of serum calcium and phosphorus in the bloodstream by enhancing the efficacy of the small intestine to absorb these minerals from the diet. At the liver, vitamin D3 or D2 is hydroxylated to 25-hydroxyvitamin D and then finally to the primary active metabolite 1,25-dihydroxyvitamin D in the kidney via further hydroxylation. This final metabolite binds to endogenous vitamin d receptors, which results in a variety of regulatory roles - including maintaining calcium balance, the regulation of parathyroid hormone, the promotion of the renal reabsorption of calcium, increased intestinal absorption of calcium and phosphorus, and increased calcium and phosphorus mobilization of calcium and phosphorus from bone to plasma to maintain balanced levels of each in bone and the plasma. In particular, calcitriol interacts with vitamin D receptors in the small intestine to enhance the efficiency of intestinal calcium and phosphorous absorption from about 10-15% to 30-40% and 60% increased to 80%, respectively. Furthermore, calcitriol binds with vitamin D receptors in osteoblasts to stimulate a receptor activator of nuclear factor kB ligand (or RANKL) which subsequently interacts with receptor activator of nuclear factor kB (NFkB) on immature preosteoclasts, causing them to become mature bone-resorbing osteoclasts. Such mature osteoclasts ultimately function in removing calcium and phosphorus from bone to maintain blood calcium and phosphorus levels. Moreover, calcitriol also stimulates calcium reabsorption from the glomerular filtrate in the kidneys. Additionally, it is believed that when calcitriol binds with nuclear vitamin D receptors, that this bound complex itself binds to retinoic acid X receptor (RXR) to generate a heterodimeric complex that consequently binds to specific nucleotide sequences in the DNA called vitamin D response elements. When bound, various transcription factors attach to this complex, resulting in either up or down-regulation of the associated gene's activity. It is thought that there may be as much as 200 to 2000 genes that possess vitamin D response elements or that are influenced indirectly to control a multitude of genes across the genome. It is in this way that cholecalciferol is believed to function in regulating gene transcription associated with cancer risk, autoimmune disorders, and cardiovascular disease linked to vitamin D deficiency. In fact, there has been some research to suggest calcitriol may also be able to prevent malignancies by inducing cellular maturation and inducing apoptosis and inhibiting angiogenesis, exhibit anti-inflammatory effects by inhibiting foam cell formation and promoting angiogenesis in en

Pharmacodynamics

The in vivo synthesis of the predominant two biologically active metabolites of vitamin D occurs in two steps. The first hydroxylation of vitamin D3 cholecalciferol (or D2) occurs in the liver to yield 25-hydroxyvitamin D while the second hydroxylation happens in the kidneys to give 1, 25-dihydroxyvitamin D. These vitamin D metabolites subsequently facilitate the active absorption of calcium and phosphorus in the small intestine, serving to increase serum calcium and phosphate levels sufficiently to allow bone mineralization. Conversely, these vitamin D metabolites also assist in mobilizing calcium and phosphate from bone and likely increase the reabsorption of calcium and perhaps also of phosphate via the renal tubules. There exists a period of 10 to 24 hours between the administration of cholecalciferol and the initiation of its action in the body due to the necessity of synthesis of the active vitamin D metabolites in the liver and kidneys. It is parathyroid hormone that is responsible for the regulation of such metabolism at the level of the kidneys.

Mechanism of action

Exposure to low temperatures often causes allergic responses or urticaria. Similarly, menthol, a common food additive is also known to cause urticaria, asthma, and rhinitis. However, despite the obvious clinical implications, the molecular mechanisms responsible for inducing allergic responses to low temperatures and menthol have not been determined. Because a non-selective cation channel, transient receptor potential subtype M8 (TRPM8) is activated by cold and menthol, we hypothesized that this channel mediates cold- and menthol-induced histamine release in mast cells. Here, we report that TRPM8 is expressed in the basophilic leukemia mast cell line, RBL-2H3, and that exposure to menthol or low temperatures induced Ca(2+) influx in RBL-2H3 cells, which was reversed by a TRPM8 blocker. Furthermore, menthol, a TRPM8 agonist, induced the dose-dependent release of histamine from RBL-2H3 cells. When TRPM8 transcripts were reduced by siRNA (small interfering RNA), menthol- and cold-induced Ca(2+) influx and histamine release were significantly reduced. In addition, subcutaneous injection of menthol evoked scratching, a typical histamine-induced response which was reversed by a TRPM8 blocker. Thus, our findings indicate that TRPM8 mediates the menthol- and cold-induced allergic responses of mast cells, and suggest that TRPM8 antagonists be viewed as potential treatments for cold- and menthol-induced allergies. /DL-Menthol/ Menthol's characteristic cooling sensation is due, in part, to the activation of sensory neurons generally termed transient receptor potential (TRP) channels, in particular transient receptor potential melastatin family member 8 (TRPM8) and transient receptor potential subfamily A, member 1 (TRPA1). Menthol acts upon TRPM8 receptors by rapidly increasing intracellular calcium and mobilizing calcium flux through the channels to induce cold response signals at the application site. Aside from its cold-inducing sensation capabilities, menthol exhibits cytotoxic effects in cancer cells, induces reduction in malignant cell growth, and engages in synergistic excitation of GABA receptors and sodium ion channels resulting in analgesia. /DL-Menthol/ In recent years, the transient receptor potential melastatin member 8 (TRPM8) channel has emerged as a promising prognostic marker and putative therapeutic target in prostate cancer. We have found that forced overexpression of TRPM8 in PC-3 cells can inhibit the cell proliferation and motility probably through the TRPM8 activation. In this study, we aimed to investigate whether activating the TRPM8 channel by its selective agonist menthol can inhibit the proliferation and motility of androgen-independent prostate cancer (AIPC) with remarkable expression of TRPM8. Menthol is a naturally occurring compound, which has been widely used in cosmetics and pharmaceutical products, and also as flavoring in food. DU145 cells are androgen-independent but have a remarkable expression of TRPM8. The demonstration of the existence of TRPM8 and the absence of TRPA1 in DU145 cells provided the foundation for the following experiments, because both TRPM8 and TRPA1 are molecular targets of menthol. The outcome of MTT assay indicated that menthol inhibited the cell growth (p < 0.01). Cell cycle distribution and scratch assay analysis revealed that menthol induced cell cycle arrest at the G(0)/G(1) phase (p < 0.01). Furthermore, menthol inhibited the migration of DU145 cells by downregulating the focal-adhesion kinase. So it suggests that the activation of the existing TRPM8 channels may serve as a potential and pragmatic treatment for those AIPC with remarkable expression of TRPM8, and menthol is a useful compound for future development as an anticancer agent. /DL-Menthol/

Mechanism of action

... The primary mechanisms by which methyl mercaptan has caused death and induces coma appear to reside with its reversible inhibition of cytochrome c oxidase (as in cyanide and hydrogen sulfide poisoning) and its inhibition of brain sodium and potassium ATPase activity. Methanethiol (CH3SH) has been implicated in the pathogenesis of hepatic coma. Studies are presented to identify the possible biochemical basis of anesthesia-like effects of methanethiol and those features, which distinguish such effects from common anesthetics and may represent the basis of its toxicity. CH3SH was found to stabilize erythrocyte membranes against hypotonic hemolysis at relatively low concentrations. At 37 degrees C the AH25 value for human erythrocyte antihemolysis was observed at a concentration of 0.34 mumol of CH3SH bound per mg of erythrocyte protein. Similar results were obtained with rat erythrocytes. This property of CH3SH is in common with other anesthetic agents. Anesthetic agents also inhibit the membrane-associated Na+, K+-adenosine triphosphatase (ATPase); however, for effective and nontoxic agents of this type the inhibition of ATPase activity is elicited at concentrations which are at least an order of magnitude higher than those which influence the membrane stability characterized by the antihemolysis effect. CH3SH was also found to inhibit the membrane Na+,K+-ATPase activity. The I25 value for the inhibition of human erythrocyte ATPase activity was obtained at CH3SH concentration of 0.12 mM which corresponded to 0.3 umol of CH3SH bound per mg of erythrocyte membrane protein. Rat erythrocyte membrane ATPase was somewhat more sensitive to CH3SH. In all cases, the binding of CH3SH to erythrocytes occurred primarily on the membrane. These results indicate that no differential exists with respect to the dose-response of these two activities associated with human erythrocyte membrane. Pulpal disease is intimately associated with the immune system's response to bacteria products. Clinical pathology is mediated in part by the production of pyrogenic cytokines, especially interleukin (IL)-1, tumor necrosis factor (TNF)-alpha, and IL-6. Methyl mercaptan (CH3SH), a volatile sulfur compound produced by anaerobic Gram-negative bacteria, has been shown to contribute to the production of IL-1 by human mononuclear cells. In this report, /the authors/ investigated the production of IL-1, TNF-alpha, and IL-6 by human pulp fibroblasts when stimulated for various periods of time with lipopolysaccharide (LPS) with or without the presence of CH3SH. We found that LPS and CH3SH had no effect on the production of IL-1 or TNF-alpha. However, LPS stimulated IL-6 production, and this production was augmented when CH3SH was present. /It was concluded/ that the volatile sulfur compound CH3SH plays a role in activation and modulation of the immune response through its role in production of IL-6. Hydrogen sulfide (H2S) and methyl mercaptan (CH3SH) are the volatile sulfur compounds (VSC) that were investigated for a possible role in the etiology of periodontal disease. The results show that the permeability of porcine non-keratinized sublingual mucosa is increased by up to 75% or 103% following exposure to H2S and CH3SH, respectively. The effect may be attributed to VSC reaction with tissue components resulting in alteration in the integrity of the tissue barrier. The increase in permeability of the mucosa to (35)S-Na2SO4 was dependent on both the time of exposure and concentration of VSC in the head-space. The (35)S-H2S was retained by the mucosal tissue and was able to penetrate the intact layers consisting of non-keratinized epithelium, basal membrane, and connective tissue. Treatment of the mucosa with 0.22% ZnCl2, either prior to or after exposure to CH3SH, nullified the effect of CH3SH and restored the permeability to a state similar to that observed in control 95% air/5% CO2 systems. For more Mechanism of Action (Complete) data for METHYL MERCAPTAN (10 t

Mechanism of action

Although systemically applied nanoparticles are quickly taken up by phagocytic cells, mainly macrophages, the interactions between engineered nanoparticles and macrophages are still not well defined. ...Therefore ... the uptake of diagnostically used carboxydextran-coated superparamagnetic iron oxide nanoparticles of 60 nm (SPIO) and 20 nm (USPIO) by human macrophages /was analyzed/. By pharmacological and in vitro knockdown approaches, the principal uptake mechanism for both particles was identified as clathrin-mediated, scavenger receptor A-dependent endocytosis... /Iron oxide nanoparticles/ ... /It has been/ suggested that ferric oxide serves as a carcinogenic cofactor either by retarding the clearance of inhaled carcinogens or by inducing cytopathological changes which make the cells of the respiratory tract more prone to develop cancer when exposed to carcinogenic substances.